A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees

By Schneider J.   Langermans J.A.M.   Gilbert S.C.   Blanchard T.J.   Twigg S.   Naitza S.   Hannan C.M.   Aidoo M.   Crisanti A.   Robson K.J.   Smith G.L.   Hill A.V.S.   Thomas A.W.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4595-4602

Elsevier

Access to resources Recommend Favorite

Effect of vaccination with 3 recombinant asexual-stage malaria antigens on initial growth rates of Plasmodium falciparum in non-immune volunteers

By Lawrence G.   Cheng Q.Q.   Reed C.   Taylor D.   Stowers A.   Cloonan N.   Rzepczyk C.   Smillie A.   Anderson K.   Pombo D.   Allworth A.   Eisen D.   Anders R.   Saul A.  

Vaccine, Vol. 18, Iss. 18, 2000-03 ,pp. : 1925-1931

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus - poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans

By Kanesa-thasan N.   Smucny J.J.   Hoke  

Vaccine, Vol. 19, Iss. 4, 2000-10 ,pp. : 483-491

Elsevier

Access to resources Recommend Favorite

Lack of toxicity and persistence in the mouse associated with administration of candidate DNA- and modified vaccinia virus Ankara (MVA)-based HIV vaccines for Kenya

By Hanke T.   McMichael A.J.   Samuel R.V.   Powell L.A.J.   McLoughlin L.   Crome S.J.   Edlin A.  

Vaccine, Vol. 21, Iss. 1, 2002-11 ,pp. : 108-114

Elsevier

Access to resources Recommend Favorite

Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: enhanced CD8+ T cell immunogenicity and protective efficacy in the influenza and malaria models

By Degano P.   Schneider J.   Hannan C.M.   Gilbert S.C.   Hill A.V.S.  

Vaccine, Vol. 18, Iss. 7, 1999-11 ,pp. : 623-632

Elsevier

Access to resources Recommend Favorite